Aufklappen
Schliessen
- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten |
|---|---|
| 15:12 | Probiodrug appoints Ulrich Dauer as CEO |
| 12:42 | Redx appoints senior AstraZeneca executive as new CEO |
| 12:42 | PureTech Health appoints Joep Muijrers as chief financial officer |
| 12:12 | FDA advisors back Lilly/Incyte's rheumatoid arthritis drug |
| 12:12 | MHRA bans valproate without pregnancy prevention programme |
| 11:42 | EU reviewing MSD's Keytruda/chemo combo |
| 11:12 | FDA rejects Pfizer's Herceptin biosimilar |
| 11:12 | AstraZeneca lung cancer combo fails to hit targets |
| Mo | Neil Levinson joins Accretio as strategy director |
| Mo | Ministers write letter to Vertex over Orkambi debate |
| Mo | Fresenius pulls out of $4.3bn Akorn merger |
| Mo | Takeda ups its offer for Shire |
| Mo | CHMP rejects AB Science's ALS drug |
| Fr | Communications Team of the Year: Join our exclusive alumni of fellow Pharma winners! |
| Fr | Clinical Researcher of the Year finalists to face toughest challenge yet |
| Fr | Shire turns down Takeda's advances |
| Fr | FDA advisors back approval of GW's Epidiolex |
| Fr | US widens use of AstraZeneca' Tagrisso in lung cancer |
| Fr | Merck sells consumer healthcare unit to P&G |
| Fr | Marketer of the Year announces exciting new category |
| Do | FDA clears first therapy for inherited rickets |
| Do | Final NHS nod for Roche's RoActemra |
| Do | GW's Epidiolex takes a leap toward US approval |
| Do | MPs slate rate of progress on NHS cyber security |
| Mi | CR UK, AACR form international cancer alliance |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von